ApprovalTrail

Drug · DIN 02242374

PANCREASE CAPSULES

No: no longer authorized

The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.

Status Cancelled Post Market since August 8, 2008; first marketed May 11, 2001.
Drug Identification Number (DIN)
02242374
Company (DIN owner)
Janssen Inc.Toronto, Ontario, Canada
Schedule
Non-prescription drugs
Dosage form
Capsule (Sustained-Release)
Route
Oral
Therapeutic class (ATC)
Multienzymes (lipase, protease etc) A09AA02
Class
Human
Record last updated
March 22, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
LIPASE4500 UNITSRC
AMYLASE20000 UNITSRC
PROTEASE25000 UNITSRC